Published Date : Mar 06, 2017
Albany, New York, March 06, 2017: The new report added to MarketResearchReports.biz analyzes the present scenario and growth prospects of the global percutaneous coronary interventions market. The report offers an overview of the market landscape and key vendors and discusses the chief drivers and restraints of market growth. The report, titled ‘MediPoint: Percutaneous Coronary Interventions - Global Analysis and Market Forecasts’, predicts the market to progress at a CAGR of 3.5% from 2015 to 2022.
Coronary disease, also known as heart disease, affects millions worldwide. Smooth and elastic arteries start developing plaque in their inner walls, making them narrowed and rigid. This restricts the flow of blood to the heart, which falls short of oxygen, ultimately leading to sudden cardiac arrest. Through percutaneous coronary interventions (PCIs) such as stenting and coronary angioplasty, a wide range of heart diseases can be treated.
The most commonly used coronary stents include bare metal stents, drug-eluting stents (DES), covered stents, and bioabsorbable stents (BAS). After PCI, for the initial three months, stents play tha very crucial role; post PCI the artery can remain open on its own. This is the ground on the basis of which bioresorbable stents are developed, as they naturally dissolve once they are no longer needed.
The demand for percutaneous coronary intervention has gone up manifold due to increasing incidence of heart diseases, growing diabetic patient pool, and rising procedure volumes. With an objective to meet the requirements of complex lesions and challenging population, newer technologies, such as BASes and third generation DESes, have been introduced.
For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/903167
Due to recent developments, commercialization of various drug-eluting stents, and repeated innovations, the next generation of DESes is set to prosper. Bioabsorbable stents also show a great deal of progress as they are capable of significantly reducing restenosis rates and allow for vessel remodeling.
The global percutaneous coronary interventions market is geographically segmented into Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. The demand for percutaneous coronary interventions is high in the North American region due to increased rate of coronary diseases, large pool of diabetic population, high per capita income, availability of advanced technologies, and better healthcare infrastructure.
The Asia Pacific region is also considered a lucrative market for percutaneous coronary interventions. Coronary stents are in significant demand in this region. Plus, increased income and government initiatives are propelling the growth of the global percutaneous coronary interventions market.
The key players operating in the global percutaneous coronary interventions market include Terumo Abbott Vascular, B. Braun, Medtronic, Biotronik, Boston Scientific, and Biosensors International.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org